Study: JZP458 Shows Positive Benefit in Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
June 9th 2022JZP458, a recombinant Erwinia-derived ASNase from a Pseudomonas fluorescens expression platform, was previously approved by the FDA for patients with ALL/LBL who had developed hypersensitivity to Escherichia coli (E. coli)–derived ASNase.
Read More
Pharmacy Focus: Public Health Matters- Global Health from the Pharmacist Perspective
June 9th 2022Abrons’ work with global underserved care extends to multiple countries; however, her primary work centers around partnerships in Dominica, collaborating with a local eco-based, social entrepreneur, the Ministry of Health, and a private pharmacy.
Listen
Drug Sequestration in the Management of Patients with Extracorporeal Membrane Oxygenation Support
June 8th 2022Dosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.
Read More
FDA Advisory Committee Recommends EUA for Novavax COVID-19 Vaccine
June 8th 2022The FDA Vaccines and Related Biological Products Advisory Committee voted nearly unanimously for an emergency use authorization for the Novavax COVID-19 vaccine, NVX-CoV2373, for use in individuals 18 years of age and older.
Read More
Trial Results Show Improved Distant Metastasis-Free Survival With Pembrolizumab in Melanoma
June 8th 2022Scot Ebbinghaus, MD, vice president of oncology clinical research at Merck, discussed the growing body of research surrounding pembrolizumab (Keytruda) and what it is currently being investigated for.
Read More